Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s): CRDL | T.CRDL.W.A

Healthcare

Cardiol Therapeutics Inc. (Cardiol) is a Canada-based clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). The Company's lead product, CardiolRx, is a pharmaceutically produced oral cannabidiol formulation that is in a Phase II/III study in hospitalized patients testing positive for COVID-19 with a prior history of, or risk factors for, cardiovascular disease. Cardiol has also received clearance from the Food and Drug Administration (FDA) for its investigational new drug (IND) application for a Phase II international trial that investigates the anti-inflammatory and anti- fibrotic properties of CardiolRx in patients with acute myocarditis, which is a common cause of sudden cardiac death in people under 35 years of age. In addition, Cardiol is developing a subcutaneous formulation of CardiolRx and other anti-inflammatory therapies for the treatment of chronic heart failure.

TSX:CRDL - Post by User

Cardiol Therapeutics Inc > Did the World Miss Something?

<< Previous

Bullboard Posts

Next >>

Comment by cascao1on Dec 16, 2020 8:58pm

87 Views

Post# 32125264

RE:RE:Did the World Miss Something?

You guys are funny...you're still here! Stock goes up 15% in the last couple of days all I hear is crickets stock goes down 2 pennies and of corse you have to add your 2 cents. Well in case you didn't notice Maple and giveme, no one cares what you think. Good luck on your short giveme and Maple you should have held on to your shares. Take it eazy!

<< Previous

Bullboard Posts

Next >>

Investing in Canada's lumber market